Oppenheimer Asset Management Inc. Amicus Therapeutics, Inc. Transaction History
Oppenheimer Asset Management Inc.
- $6.65 Billion
- Q1 2024
A detailed history of Oppenheimer Asset Management Inc. transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Oppenheimer Asset Management Inc. holds 51,341 shares of FOLD stock, worth $514,436. This represents 0.01% of its overall portfolio holdings.
Number of Shares
51,341
Previous 51,183
0.31%
Holding current value
$514,436
Previous $726,000
16.8%
% of portfolio
0.01%
Previous 0.01%
Shares
13 transactions
Others Institutions Holding FOLD
# of Institutions
273Shares Held
325MCall Options Held
841KPut Options Held
353K-
Vanguard Group Inc Valley Forge, PA28.2MShares$283 Million0.01% of portfolio
-
Perceptive Advisors LLC New York, NY28.1MShares$281 Million6.94% of portfolio
-
Avoro Capital Advisors LLC New York, NY27.4MShares$275 Million3.89% of portfolio
-
Black Rock Inc. New York, NY22.8MShares$229 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA18.8MShares$188 Million0.04% of portfolio
About AMICUS THERAPEUTICS, INC.
- Ticker FOLD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 280,497,984
- Market Cap $2.81B
- Description
- Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...